Report Detail
Global (United States, European Union and China) Subcutaneous Drug Delivery Equipment Market Research Report 2019-2025
- RnM3348304 |
- 23 April, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
In 2019, the market size of Subcutaneous Drug Delivery Equipment is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Subcutaneous Drug Delivery Equipment.
This report studies the global market size of Subcutaneous Drug Delivery Equipment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Subcutaneous Drug Delivery Equipment production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Boehringer Ingelheim
Eli Lily
Galaxo
HMD pharmaceuticals
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Teva Pharmaceutical
Zogenix
Market Segment by Product Type
Syringe Based Subcutaneous Drug Delivery
Subcutaneous Implants
Pen Systems for Subcutaneous Drug Delivery
Auto Injectors
Pump Based Drug Delivery Systems
Market Segment by Application
In-Patient
Out-Patient
Clinic
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Subcutaneous Drug Delivery Equipment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Subcutaneous Drug Delivery Equipment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Subcutaneous Drug Delivery Equipment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Subcutaneous Drug Delivery Equipment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Syringe Based Subcutaneous Drug Delivery
- 1.3.3 Subcutaneous Implants
- 1.3.4 Pen Systems for Subcutaneous Drug Delivery
- 1.3.5 Auto Injectors
- 1.3.6 Pump Based Drug Delivery Systems
- 1.4 Market Segment by Application
- 1.4.1 Global Subcutaneous Drug Delivery Equipment Market Share by Application (2019-2025)
- 1.4.2 In-Patient
- 1.4.3 Out-Patient
- 1.4.4 Clinic
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Subcutaneous Drug Delivery Equipment Production Value 2014-2025
- 2.1.2 Global Subcutaneous Drug Delivery Equipment Production 2014-2025
- 2.1.3 Global Subcutaneous Drug Delivery Equipment Capacity 2014-2025
- 2.1.4 Global Subcutaneous Drug Delivery Equipment Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Subcutaneous Drug Delivery Equipment Market Size CAGR of Key Regions
- 2.2.2 Global Subcutaneous Drug Delivery Equipment Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Subcutaneous Drug Delivery Equipment Capacity by Manufacturers
- 3.1.2 Global Subcutaneous Drug Delivery Equipment Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Subcutaneous Drug Delivery Equipment Revenue by Manufacturers (2014-2019)
- 3.2.2 Subcutaneous Drug Delivery Equipment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Subcutaneous Drug Delivery Equipment Market Concentration Ratio (CR5 and HHI)
- 3.3 Subcutaneous Drug Delivery Equipment Price by Manufacturers
- 3.4 Key Manufacturers Subcutaneous Drug Delivery Equipment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Subcutaneous Drug Delivery Equipment Market
- 3.6 Key Manufacturers Subcutaneous Drug Delivery Equipment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Syringe Based Subcutaneous Drug Delivery Production and Production Value (2014-2019)
- 4.1.2 Subcutaneous Implants Production and Production Value (2014-2019)
- 4.1.3 Pen Systems for Subcutaneous Drug Delivery Production and Production Value (2014-2019)
- 4.1.4 Auto Injectors Production and Production Value (2014-2019)
- 4.1.5 Pump Based Drug Delivery Systems Production and Production Value (2014-2019)
- 4.2 Global Subcutaneous Drug Delivery Equipment Production Market Share by Type
- 4.3 Global Subcutaneous Drug Delivery Equipment Production Value Market Share by Type
- 4.4 Subcutaneous Drug Delivery Equipment Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Subcutaneous Drug Delivery Equipment Consumption by Application
6 Production by Regions
- 6.1 Global Subcutaneous Drug Delivery Equipment Production (History Data) by Regions 2014-2019
- 6.2 Global Subcutaneous Drug Delivery Equipment Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Subcutaneous Drug Delivery Equipment Production Growth Rate 2014-2019
- 6.3.2 United States Subcutaneous Drug Delivery Equipment Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Subcutaneous Drug Delivery Equipment Import & Export
- 6.4 European Union
- 6.4.1 European Union Subcutaneous Drug Delivery Equipment Production Growth Rate 2014-2019
- 6.4.2 European Union Subcutaneous Drug Delivery Equipment Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Subcutaneous Drug Delivery Equipment Import & Export
- 6.5 China
- 6.5.1 China Subcutaneous Drug Delivery Equipment Production Growth Rate 2014-2019
- 6.5.2 China Subcutaneous Drug Delivery Equipment Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Subcutaneous Drug Delivery Equipment Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Subcutaneous Drug Delivery Equipment Consumption by Regions
- 7.1 Global Subcutaneous Drug Delivery Equipment Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Subcutaneous Drug Delivery Equipment Consumption by Type
- 7.2.2 United States Subcutaneous Drug Delivery Equipment Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Subcutaneous Drug Delivery Equipment Consumption by Type
- 7.3.2 European Union Subcutaneous Drug Delivery Equipment Consumption by Application
- 7.4 China
- 7.4.1 China Subcutaneous Drug Delivery Equipment Consumption by Type
- 7.4.2 China Subcutaneous Drug Delivery Equipment Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Subcutaneous Drug Delivery Equipment Consumption by Type
- 7.5.2 Rest of World Subcutaneous Drug Delivery Equipment Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Boehringer Ingelheim
- 8.1.1 Boehringer Ingelheim Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.1.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.1.5 Boehringer Ingelheim Recent Development
- 8.2 Eli Lily
- 8.2.1 Eli Lily Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.2.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.2.5 Eli Lily Recent Development
- 8.3 Galaxo
- 8.3.1 Galaxo Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.3.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.3.5 Galaxo Recent Development
- 8.4 HMD pharmaceuticals
- 8.4.1 HMD pharmaceuticals Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.4.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.4.5 HMD pharmaceuticals Recent Development
- 8.5 Merck
- 8.5.1 Merck Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.5.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.5.5 Merck Recent Development
- 8.6 Novartis
- 8.6.1 Novartis Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.6.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.6.5 Novartis Recent Development
- 8.7 Novo Nordisk
- 8.7.1 Novo Nordisk Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.7.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.7.5 Novo Nordisk Recent Development
- 8.8 Pfizer
- 8.8.1 Pfizer Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.8.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.8.5 Pfizer Recent Development
- 8.9 Sanofi
- 8.9.1 Sanofi Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.9.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.9.5 Sanofi Recent Development
- 8.10 Teva Pharmaceutical
- 8.10.1 Teva Pharmaceutical Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Subcutaneous Drug Delivery Equipment
- 8.10.4 Subcutaneous Drug Delivery Equipment Product Introduction
- 8.10.5 Teva Pharmaceutical Recent Development
- 8.11 Zogenix
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Subcutaneous Drug Delivery Equipment Capacity, Production Forecast 2019-2025
- 9.1.2 Global Subcutaneous Drug Delivery Equipment Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Subcutaneous Drug Delivery Equipment Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Subcutaneous Drug Delivery Equipment Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Subcutaneous Drug Delivery Equipment Production Forecast by Type
- 9.7.2 Global Subcutaneous Drug Delivery Equipment Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Subcutaneous Drug Delivery Equipment Sales Channels
- 10.2.2 Subcutaneous Drug Delivery Equipment Distributors
- 10.3 Subcutaneous Drug Delivery Equipment Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Subcutaneous Drug Delivery Equipment. Industry analysis & Market Report on Subcutaneous Drug Delivery Equipment is a syndicated market report, published as Global (United States, European Union and China) Subcutaneous Drug Delivery Equipment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Subcutaneous Drug Delivery Equipment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
